Skip to main content

Market Overview

Citigroup Reduces FXCM's Price Target, Maintains At Sell/High Risk Rating

Share:

William Katz of Citigroup on Tuesday maintained a Sell/High Risk rating on shares of FXCM Inc (NYSE: FXCM) with a price target lowered by $4.25 to $0.75 following details that emerged over the weekend of Leucadia's $300 million rescue package.

Katz notes that the “onerous” terms include an annual interest rate of 10 percent, increasing by 1.5 percent per annum each quarter, up to 17 percent. The loan is also subject to mandatory repayments and restructure covenants.

Katz states that the company will likely never achieve its prior market cap of $1.3 billion (now estimated at around $50 million to $68 million), even assuming a possible sale to a strategic buyer. The analyst adds that based on the disclosure, FXCM will try to sell itself by April 2015.

Shares of FXCM were down 90 percent Tuesday morning.

Latest Ratings for FXCM

DateFirmActionFromTo
May 2015Keefe Bruyette & WoodsMaintainsUnderperform
Mar 2015CitigroupMaintainsSell
Mar 2015Keefe Bruyette & WoodsDowngradesMarket PerformUnderperform

View More Analyst Ratings for FXCM
View the Latest Analyst Ratings

 

Related Articles (FXCM)

View Comments and Join the Discussion!

Posted-In: Citigroup fxcm Leucadia Swiss Franc William KatzAnalyst Color Price Target Analyst Ratings

Latest Ratings

StockFirmActionPT
SAMEvercore ISI GroupMaintains1,500.0
SEAutonomous ResearchInitiates Coverage On378.0
ALHCMorgan StanleyInitiates Coverage On36.0
ALHCRaymond JamesInitiates Coverage On30.0
HAEMorgan StanleyDowngrades83.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
SPAC
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com